Senators Ask FDA To Review Compounder’s Super Bowl Ad

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Senators Ask FDA To Review Compounder’s Super Bowl Ad

J.W. Schomisch

February 12, 2025 at 09:46 AM EST

Two senators asked the FDA to review a Super Bowl ad from drug compounder Hims & Hers Health Inc., which the senators contend “risks misleading patients by omitting any safety or side effect information" in its promotion of the compounder's GLP-1 weight loss medications. The letter from Sens. Dick Durbin, D-Ill., and Roger Marshall, R-Kan., said the ad “appears to showcas... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Senators Ask FDA To Review Compounder’s Super Bowl Ad

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT